Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00763269 · ClinicalTrials.gov registry record · Phase 3
The Efficacy of a Toothpaste to Reduce Sensitivity
A Phase 3 study, sponsored by Colgate Palmolive.
- Completed
- Registry status
- Phase 3
- Development phase
- 626
- Enrollment target
NCT00763269: Completed Phase 3 study, sponsored by Colgate Palmolive.
NCT00763269 is a Phase 3 study that has completed, run by Colgate Palmolive. The registered enrollment target is 626 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (19% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00763269, a Phase 3 study, has completed, sponsored by Colgate Palmolive.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 626 participants
- Enrollment target
Study Summary
Hypersensitivity
Primary Outcome
Measured with an electronic force sensing probe (Yeaple Probe): 10, 20, 30, 40, up to 50 grams of force are applied to hypersensitive tooth until pain elicited. Grams of force needed to elicit pain are recorded as hypersensitivity score for the tooth. For Tactile Hypersensitivity: The higher the score (the more grams of force needed to elicit a response of pain), the lower the hypersensitivity. Hypersensitivity scores on a per study subject basis are recorded as mean scores of two hypersensitive
Interventions
- DRUG Triclosan, fluoride
- DRUG Triclosan, Silicon dioxide, fluoride
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 626 participants |
| Start Date | 2008-09 |
| Est. Completion | 2008-12 |
| Phase | Phase 3 |
What the finished NCT00763269 record still lists
NCT00763269 is an interventional study that assigns participants to a tested intervention. The registered 626 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (19% lower).
The record links to 0 conditions, and to 2 interventions - of which Triclosan, fluoride is the first listed.
NCT00763269 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00763269 about?
NCT00763269 is a clinical study titled "The Efficacy of a Toothpaste to Reduce Sensitivity". Hypersensitivity
What is the current status of trial NCT00763269?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 626 participants. The study started on 2008-09. Estimated completion is 2008-12.
What interventions are being tested in trial NCT00763269?
The interventions under investigation include: Triclosan, fluoride (DRUG), Triclosan, Silicon dioxide, fluoride (DRUG).
Who is sponsoring clinical trial NCT00763269?
This trial is sponsored by Colgate Palmolive, which has 51 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00763269's enrollment target sits among peer trials
626 586th of 2000 higher than 1,415 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06040827 · 626 participants
A Multicenter, Postmarket Surveillance Study of Subjects With the Canary canturioTM te Tibial Extension
- NCT05349227 · 625 participants · NA
Comprehensive Outcomes for After Cancer Health
- NCT06103864 · 625 participants · Phase 3
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer
- NCT06230510 · 625 participants · NA
Milk-Tot Study: Impact of Whole Versus Low-fat Milk on Child Health
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia